EPISODE · Sep 16, 2026 · 48 MIN
Europe Is Not a Rescue Plan ft. Jamie Pearson
from The Dime · host Jamie Pearson, Bryan Fields
Global expansion is often pitched as an opportunity. For an undisciplined cannabis company, it is an expensive way to expose every weakness at once.International markets reward specific operating capabilities, not ambition alone. Pharmaceutical standards, reliable supply, disciplined data use, and local market fit determine whether an operator can cross borders without compounding its problems.This week we sit down with Jamie PearsonEU GMP's undervalued strategic valueRegulation exposes operating weaknessMatching strength to global marketsOn The Dime, host Bryan Fields speaks with Jamie L. Pearson, President and Founder of New Holland Group, about European cannabis expansion, medical cannabis supply chains, and building operations that can succeed across borders.Key TakeawaysJamie explains why European medical cannabis markets call for pharmaceutical reliability, consistent supply, and a different operating model from adult-use brands.EU GMP (European Union Good Manufacturing Practice) capability can be a strategic asset for cannabis manufacturing and international market entry.Match the company's repeatable strengths to local buyers, regulations, and supply chains before choosing a market.Prove standard operating procedures (SOPs) and quality controls in another U.S. state before adding language, currency, and cross-border complexity.The discussion spans the UK, Germany, Switzerland, Slovenia, Portugal, and Brazil, alongside cannabis data and U.S. hemp regulation.Chapters00:00 Regulation is breaking the data layer02:49 Finding trend data upstream06:24 What EU GMP actually demands10:19 Why compliant facilities become strategic assets16:13 Canada-Europe regulatory harmony19:20 Europe is medical first25:28 First-mover advantage vs. disciplined execution27:59 Medical supply rewards repeatability30:48 Weak operations do not travel32:24 Switzerland, Slovenia, and Portugal35:54 Brazil and partner requirements37:07 Practice expansion before global scale40:08 The hidden U.S. hemp market43:29 Turning customers into political force47:10 Directness as respectGuest LinksJamie L. Pearson — official bioNew Holland GroupNew Holland Group on LinkedInRelated EpisodeGermany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka — continue exploring Germany's cannabis market and operational discipline.Our LinksThe Dime Podcast — websiteBryan Fields on XThe Dime on XThe Dime on YouTubeThe Dime on InstagramEighth RevolutionNewton Insights — insights for extraction teamsFollow The Dime for more conversations on cannabis business, operations, and international markets. Share this episode with an operator considering expansion. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
What this episode covers
Jamie Pearson of New Holland Group joins Bryan Fields on The Dime to discuss European cannabis expansion, EU GMP standards, medical cannabis supply chains, and why operational discipline and market fit matter before entering international markets.
Ready to play
Europe Is Not a Rescue Plan ft. Jamie Pearson
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.